InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Schwab Gisela, Président, Développement des Produits et Affaires Médicales. Insider active across 1 companies, notably Exelixis, INC.. Cumulatively, 6 reports have been recorded. The latest transaction was disclosed on 26 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€142,27940,000 shares@ €3.5570.0012% mcap33.5% of flow
Common Stock
SEC:0000939767-21-000074·
€142,27940,000 shares@ €3.5570.0012% mcap16.8% of flow
Common Stock
SEC:0000939767-21-000074:0·
€124,65335,000 shares@ €3.56150.0011% mcap29.4% of flow
Common Stock
SEC:0000939767-21-000073·
€124,65335,000 shares@ €3.56150.0011% mcap14.7% of flow
Common Stock
SEC:0000939767-21-000073:0·
€157,320100,000 shares@ €1.57320.0014% mcap37.1% of flow
Common Stock
SEC:0000939767-21-000050·
€157,320100,000 shares@ €1.57320.0014% mcap18.5% of flow
Common Stock
SEC:0000939767-21-000050:0·
6 of 6 declarations
About Schwab Gisela
Gisela Schwab is the President of Product Development and Medical Affairs at Exelixis, Inc. She is responsible for product development strategy and medical innovation. Gisela plays a key role in the strategic direction of Exelixis, a company specializing in biotechnology.
